| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(99)00574-4 |
| P698 | PubMed publication ID | 10676681 |
| P2093 | author name string | C P Cannon | |
| D L Weiner | |||
| E M Antman | |||
| E Braunwald | |||
| D A Morrow | |||
| N Rifai | |||
| C H McCabe | |||
| P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability | Q33852673 | ||
| Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q34064191 | ||
| Serum amyloid A concentrations during the course of acute ischaemic heart disease | Q37208763 | ||
| Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein | Q37370255 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy | Q40870017 | ||
| Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice | Q40937418 | ||
| Role of inflammation in the pathogenesis of unstable coronary artery disease. | Q41593796 | ||
| Comparative study of serum amyloid A protein and C-reactive protein in disease | Q44838099 | ||
| C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction | Q47974191 | ||
| Inflammation, atherosclerosis, and ischemic events -- exploring the hidden side of the moon | Q48731138 | ||
| Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. | Q50866439 | ||
| Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris | Q58230337 | ||
| The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina | Q58230388 | ||
| Elevation of C-reactive protein in "active" coronary artery disease | Q68696120 | ||
| Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial | Q71512983 | ||
| Development and Characterization of a Rapid Assay for Bedside Determinations of Cardiac Troponin T | Q71807483 | ||
| Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease | Q73994849 | ||
| Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum | Q77634439 | ||
| C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor | Q106624382 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute coronary syndrome | Q266018 |
| P304 | page(s) | 358-362 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy | |
| P478 | volume | 35 |
| Q33745289 | A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A. |
| Q59356505 | ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the M |
| Q55008598 | Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A. |
| Q73902760 | Association between coronary endothelial dysfunction and local inflammation of atherosclerotic coronary arteries |
| Q88779694 | Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris |
| Q43846796 | Benefits of immediate initiation of statin therapy following successful coronary stent implantation in patients with stable and unstable angina pectoris and Q-wave acute myocardial infarction |
| Q39418140 | Clinical Laboratory Tools to Diagnose Inflammation |
| Q42867694 | Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial |
| Q35019922 | Consolidated and emerging inflammatory markers in coronary artery disease |
| Q57177490 | Current and future circulating biomarkers for cardiac amyloidosis |
| Q73682379 | Evaluation of a modified hsCRP method for point-of-service testing |
| Q34185567 | Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome |
| Q49254663 | High-Sensitivity C-Reactive Protein Is a Predictor of Coronary Microvascular Dysfunction in Patients with Ischemic Heart Disease |
| Q37393454 | High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study |
| Q77111489 | Increased circulating monocyte activation in patients with unstable coronary syndromes |
| Q35165193 | Inflammation, infection, and atherosclerosis |
| Q37698323 | Inflammatory biomarkers and coronary heart disease: from bench to bedside and back. |
| Q58313485 | Markers of inflammation and cognitive decline in an African-Caribbean population |
| Q46865491 | Microalbuminuria in patients with previous myocardial infarction |
| Q39000038 | Plaque imaging to refine indications for emerging lipid-lowering drugs |
| Q34669434 | Quantitative proteomics for cardiac biomarker discovery using isoproterenol-treated nonhuman primates |
| Q33467558 | Quick identification of acute chest pain patients study (QICS). |
| Q34374943 | Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort |
| Q35691984 | Risk Stratification in Patients with Unstable Angina and Non-ST-elevation Myocardial Infarction |
| Q38009702 | Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization? |
| Q36975612 | Secretory Phospholipase A2 Is Associated with the Odds of Acute Coronary Syndromes through Elevation of Serum Amyloid-A Protein |
| Q47287451 | Serum Amyloid A3 is a High-Density Lipoprotein-associated Acute Phase Protein |
| Q37266056 | Serum biomarkers reveal long-term cardiac injury in isoproterenol-treated African green monkeys |
| Q34592629 | Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A |
| Q34054032 | The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke |
| Q39710689 | The correlation between the cardio-ankle vascular index (CAVI) and serum amyloid A in asymptomatic Japanese subjects |
| Q44205530 | The erythrocyte adhesiveness/aggregation test (EAAT). A new biomarker to reveal the presence of low grade subclinical smoldering inflammation in individuals with atherosclerotic risk factors |
| Q91954657 | The prognostic value of serum amyloid A for long-term mortality among patients with subclinical carotid atherosclerosis |
| Q45972363 | Ultrapure dialysis water obtained with additional ultrafilter may reduce inflammation in patients on hemodialysis. |
| Q35147780 | Zinc regulates the acute phase response and serum amyloid A production in response to sepsis through JAK-STAT3 signaling |
Search more.